相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Invariant natural killer T infiltration in neuroblastoma with favorable outcome
Tomoro Hishiki et al.
PEDIATRIC SURGERY INTERNATIONAL (2018)
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients
Olivier Gasser et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
Laura Escriba-Garcia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy
Dominique Bollino et al.
TRANSLATIONAL RESEARCH (2017)
A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma
Xia-Feng Li et al.
ONCOLOGY LETTERS (2017)
CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1+ tumor cells, and extends the survival of tumor-bearing humanized mice
Lucas A. Horn et al.
ONCOTARGET (2017)
Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
Simon Gebremeskel et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Natural Killer T Cells in Cancer immunotherapy
Shiny Nair et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural Killer T Cell-Targeted Immunotherapy Mediating Long-term Memory Responses and Strong Antitumor Activity
Nyambayar Dashtsoodol et al.
FRONTIERS IN IMMUNOLOGY (2017)
Improved Detection of Cytokines Produced by Invariant NKT Cells
Duygu Sag et al.
SCIENTIFIC REPORTS (2017)
Subpopulations of natural killer-T-like cells before and after surgical treatment of laryngeal cancer
Janusz Klatka et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer
Janusz Klatka et al.
ANTICANCER RESEARCH (2017)
NKT-cell glycolipid agonist as adjuvant in synthetic vaccine
Zheng Liu et al.
CARBOHYDRATE RESEARCH (2017)
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Mark A. Exley et al.
CLINICAL CANCER RESEARCH (2017)
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
Toshiko Kamata et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
NKT cell subsets as key participants in liver physiology and pathology
Keya Bandyopadhyay et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Development of invariant natural killer T cells
Laurent Gapin
CURRENT OPINION IN IMMUNOLOGY (2016)
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
Gengwen Tian et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The cytokine profile of human NKT cells and PBMCs is dependent on donor sex and stimulus
Hannah Bernin et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2016)
Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling
Di Xie et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
Daisuke Yamada et al.
STEM CELLS (2016)
Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer
Liu-sheng Peng et al.
ONCOTARGET (2016)
Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells
Shuichi Kitayama et al.
STEM CELL REPORTS (2016)
The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
Sebastian Lundgren et al.
PLOS ONE (2016)
The percentage of iNKT cells among other immune cells at various clinical stages of laryngeal cancer
Janusz Klatka et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2016)
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
Leandro J. Carreno et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease
Michel DuPage et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression
Chao Ni et al.
CANCER LETTERS (2015)
Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
Masaru Taniguchi et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2015)
The Regulatory Role of Invariant NKT Cells in Tumor Immunity
Rosanna M. McEwen-Smith et al.
CANCER IMMUNOLOGY RESEARCH (2015)
The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8+ T cell generation
Catherine Gottschalk et al.
FRONTIERS IN IMMUNOLOGY (2015)
Type II nKT cells in inflammation, autoimmunity, microbial immunity, and cancer
Idania Marrero et al.
FRONTIERS IN IMMUNOLOGY (2015)
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
Verena K. Raker et al.
FRONTIERS IN IMMUNOLOGY (2015)
Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice
Simon Gebremeskel et al.
ONCOIMMUNOLOGY (2015)
CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
Tsung Wen Chong et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
The role of regulatory T cells in cancer immunology
Theresa L. Whiteside
IMMUNOTARGETS AND THERAPY (2015)
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey et al.
BLOOD (2014)
The immunoregulatory role of type I and type II NKT cells in cancer and other diseases
Masaki Terabe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
The Aberrant Expression of Stimulatory and Inhibitory Killer Immunoglobulin-Like Receptors in NK- and NKT-Cells Contributes to Lupus
Yanyan Bai et al.
CLINICAL LABORATORY (2014)
IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis
Ivan J. Fuss et al.
GUT (2014)
Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions
Avadhesh Kumar Singh et al.
HUMAN IMMUNOLOGY (2014)
Different subsets of natural killer T cells may vary in their roles in health and disease
Vipin Kumar et al.
IMMUNOLOGY (2014)
IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset
Duygu Sag et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Switching Invariant Natural Killer T (iNKT) Cell Response from Anticancerous to Anti-Inflammatory Effect: Molecular Bases
Xavier Laurent et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
Jie Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Function of CD3(+) CD56(+) NKT-Like Cells in HIV-Infected Individuals
Yongjun Jiang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
NKT cell networks in the regulation of tumor immunity
Faith C. Robertson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
Jie Zhao et al.
ONCOIMMUNOLOGY (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Molecular mechanisms of T-cell anergy
E. M. Kuklina
BIOCHEMISTRY-MOSCOW (2013)
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
Stephanie Corgnac et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
Daofeng Liu et al.
CLINICAL IMMUNOLOGY (2013)
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
Joel Crespo et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Multiplex and Genome-Wide Analyses Reveal Distinctive Properties of KIR+ and CD56+ T Cells in Human Blood
Wing Keung Chan et al.
JOURNAL OF IMMUNOLOGY (2013)
Nod1 and Nod2 Enhance TLR-Mediated Invariant NKT Cell Activation during Bacterial Infection
Thirumahal Selvanantham et al.
JOURNAL OF IMMUNOLOGY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
Inhibition of Tumor Angiogenesis by Interferon-gamma by Suppression of Tumor-Associated Macrophage Differentiation
Tao Sun et al.
ONCOLOGY RESEARCH (2013)
Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation
Mariolina Salio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs
Raju V. V. Tatituri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Altered Invariant Natural Killer T cell Subsets and its Functions in Patients with Oral Squamous Cell Carcinoma
A. K. Singh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells
Kelly Hudspeth et al.
FRONTIERS IN IMMUNOLOGY (2013)
The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity
Joanna Baginska et al.
FRONTIERS IN IMMUNOLOGY (2013)
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
Patrick J. Brennan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells
Wai Feng Lim et al.
STEM CELL RESEARCH & THERAPY (2013)
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
Esther M. de Kruijf et al.
BMC CANCER (2012)
Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy
Hiroshi Watarai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells
Kaoru Nagato et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
Famke L. Schneiders et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Rapamycin Combined with TGF-β Converts Human Invariant NKT Cells into Suppressive Foxp3+ Regulatory Cells
Lucia Moreira-Teixeira et al.
JOURNAL OF IMMUNOLOGY (2012)
Follicular Helper NKT Cells Induce Limited B Cell Responses and Germinal Center Formation in the Absence of CD4+ T Cell Help
Elena Tonti et al.
JOURNAL OF IMMUNOLOGY (2012)
Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses
Pheh-Ping Chang et al.
NATURE IMMUNOLOGY (2012)
Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Andrew J. Nicol et al.
CLINICAL CANCER RESEARCH (2011)
Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
Shinichiro Motohashi et al.
CLINICAL IMMUNOLOGY (2011)
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
Kazuki Yamasaki et al.
CLINICAL IMMUNOLOGY (2011)
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
Leonid S. Metelitsa
CLINICAL IMMUNOLOGY (2011)
Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: Reversing tumor-induced defects
Mark A. Exley et al.
CLINICAL IMMUNOLOGY (2011)
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis
Sandrine Aspeslagh et al.
EMBO JOURNAL (2011)
NKG2D performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d
Carlotta Kuylenstierna et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Activating and inhibitory receptors of natural killer cells
Hollie J. Pegram et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity
Jessica J. O'Konek et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Proinflammatory Environment Dictates the IL-17-Producing Capacity of Human Invariant NKT Cells
Lucia Moreira-Teixeira et al.
JOURNAL OF IMMUNOLOGY (2011)
Translational Control of NKT Cell Cytokine Production by p38 MAPK
Viswas K. Nagaleekar et al.
JOURNAL OF IMMUNOLOGY (2011)
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals
Patrick J. Brennan et al.
NATURE IMMUNOLOGY (2011)
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria
Yuki Kinjo et al.
NATURE IMMUNOLOGY (2011)
Presumed guilty: natural killer T cell defects and human disease
Stuart P. Berzins et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation
Tomonori Iyoda et al.
INTERNATIONAL IMMUNOLOGY (2010)
Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells
Hiroshi Watarai et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V alpha 14i NKT Cells
Barbara A. Sullivan et al.
JOURNAL OF IMMUNOLOGY (2010)
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
Gerhard Wingender et al.
JOURNAL OF IMMUNOLOGY (2010)
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
Carmela De Santo et al.
NATURE IMMUNOLOGY (2010)
A Comprehensive Ex Vivo Functional Analysis of Human NKT Cells Reveals Production of MIP1-α and MIP1-β, a Lack of IL-17, and a Th1-Bias in Males
Jennifer E. Snyder-Cappione et al.
PLOS ONE (2010)
Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a β-linked self-glycolipid
Philomena Arrenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Jeremy B. Swann et al.
BLOOD (2009)
Combination therapy of in vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
Naoki Kunii et al.
CANCER SCIENCE (2009)
Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family
A. C. Chan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias
A. Moretta et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity
Lydia Lynch et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Natural killer T cells in the lungs of patients with asthma
Ponpan Matangkasombut et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
V alpha 24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
NKG2A Inhibits Invariant NKT Cell Activation in Hepatic Injury
Toshihiko Kawamura et al.
JOURNAL OF IMMUNOLOGY (2009)
PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
Vrajesh V. Parekh et al.
JOURNAL OF IMMUNOLOGY (2009)
A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
Shinichiro Motohashi et al.
JOURNAL OF IMMUNOLOGY (2009)
Enrichment of Human CD4+ Vα24/Vβ11 Invariant NKT Cells in Intrahepatic Malignant Tumors
Gabriel Bricard et al.
JOURNAL OF IMMUNOLOGY (2009)
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
Bin Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation
Gerhard Wingender et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
David H. Chang et al.
BLOOD (2008)
Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
Gourapura J. Renukaradhya et al.
BLOOD (2008)
Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-α2
Stefan Fichtner-Feigl et al.
CANCER RESEARCH (2008)
Tumor-derived soluble MICs impair CD3+CD56+ NKT-like cell cytotoxicity in cancer patients
Huiming Wang et al.
IMMUNOLOGY LETTERS (2008)
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induced antitumor effects in mice
Kathrin Stirnemann et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice
Sungjune Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells
Hans J. J. van der Vliet et al.
JOURNAL OF IMMUNOLOGY (2008)
A novel subset of NK cells expressing high levels of inhibitory FcγRIIB modulating antibody-dependent function
Charles-Antoine Dutertre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
Jonathan M. Coquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NK T cells provide lipid antigen-specific cognate help for B cells
Elizabeth A. Leadbetter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo
Patricia Barral et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NKG2D ligands:: key targets of the immune response
Segundo Gonzalez et al.
TRENDS IN IMMUNOLOGY (2008)
Innate Invariant NKT Cells Recognize Mycobacterium tuberculosis-Infected Macrophages, Produce Interferon-γ, and Kill Intracellular Bacteria
Isabel Sada-Ovalle et al.
PLOS PATHOGENS (2008)
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Tetsuro Uchida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
CD1 antigen presentation: how it works
Duarte C. Barral et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Decline in number of elevated blood CD3+ CD56+ NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy
Marianne J. van den Heuvel et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2007)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11
Carlos J. Montoya et al.
IMMUNOLOGY (2007)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids
Ya-Jen Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NKT cells direct monocytes into a DC differentiation pathway
Subramanya Hegde et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Invariant NKT cells amplify the innate immune response to lipopolysalecharide
Niranjana A. Nagarajan et al.
JOURNAL OF IMMUNOLOGY (2007)
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma
Johan W. Molling et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Human Natural Killer T Cells Are Heterogeneous in Their Capacity to Reprogram Their Effector Functions
Karla A. Eger et al.
PLOS ONE (2006)
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer
Shinichiro Motohashi et al.
CLINICAL CANCER RESEARCH (2006)
CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells
Kyoko Haraguchi et al.
LEUKEMIA & LYMPHOMA (2006)
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
Yuki Kinjo et al.
NATURE IMMUNOLOGY (2006)
Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo
Gourapura J. Renukaradhya et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Increased intratumor Vα24-positive natural killer T cells:: A prognostic factor for primary colorectal carcinomas
T Tachibana et al.
CLINICAL CANCER RESEARCH (2005)
Phenotypical and functional alterations during the expansion phase of invariant Vα14 natural killer T (Vα14i NKT) cells in mice primed with α-galactosylceramide
Y Ikarashi et al.
IMMUNOLOGY (2005)
Glycolipid antigen induces long-term natural killer T cell anergy in mice
VV Parekh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Peripheral blood IFN-γ-secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load
JW Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes
DG Wei et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts
H Nishikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cell wall glycosphingolipids Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells
V Sriram et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Recognition of bacterial glycosphingolipids by natural killer T cells
Y Kinjo et al.
NATURE (2005)
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
J Mattner et al.
NATURE (2005)
Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13
JM Park et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
A Ishikawa et al.
CLINICAL CANCER RESEARCH (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Frequency of V alpha 24(+)V beta 11(+) NKT cells in peripheral blood of human kidney transplantation recipients
NZ Galante et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
A Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells
LS Metelitsa
CLINICAL IMMUNOLOGY (2004)
Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia
M Daibata et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation
M Harada et al.
INTERNATIONAL IMMUNOLOGY (2004)
Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity
M Nieda et al.
BLOOD (2004)
The T cell antigen receptor expressed by Vα14i NKT cells has a unique mode of glycosphingolipid antigen recogniton
S Sidobre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Distinct homeostatic requirements of CD4+ and CD4- subsets of Vα24-invariant natural killer T cells in humans
DV Baev et al.
BLOOD (2004)
Lysosomal glycosphingolipid recognition by NKT cells
DP Zhou et al.
SCIENCE (2004)
Mycobacterial phosphatidylinositol mannoside is a natural antigen for old-restricted T cells
K Fischer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Modulation of human Vα24+Vβ11+ NKT cells by age, malignancy and conventional anticancer therapies
T Crough et al.
BRITISH JOURNAL OF CANCER (2004)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD1: Antigen presentation and T cell function
M Brigl et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Development of innate CD4+ α-chain variable gene segment 24 (Vα24) natural killer T cells in the early human fetal thymus is regulated by IL-7
JK Sandberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection
M Brigl et al.
NATURE IMMUNOLOGY (2003)
Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatisis in MRL-lpr/lpr mice
JQ Yang et al.
JOURNAL OF IMMUNOLOGY (2003)
Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells
NY Crowe et al.
JOURNAL OF IMMUNOLOGY (2003)
CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells
SY Thomas et al.
JOURNAL OF IMMUNOLOGY (2003)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
α-galactosylceramide (KRN7000) suppression of chernical- and oncogene-dependent carcinogenesis
Y Hayakawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Cross-presentation of disialoganglioside GD3 to natural killer T cells
DY Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Vα24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells:: implications for immunotherapy
T Takahashi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Cutting edge:: Influence of the TCR Vβ domain on the avidity of CD1d:α-galactosylceramide binding by invariant Vα14 NKT cells
J Schümann et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells
LS Metelitsa et al.
LEUKEMIA (2003)
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes
G Galli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
In vitro differentiation of natural killer T cells from human cord blood CD34+ cells
SY Woo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment
JK Sandberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide
J Schmieg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction
N Guerra et al.
BLOOD (2002)
CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells
S Sidobre et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
MP Martin et al.
NATURE GENETICS (2002)
Trafficking machinery of NKT cells:: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity
CH Kim et al.
BLOOD (2002)
Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide
K Yanagisawa et al.
JOURNAL OF IMMUNOLOGY (2002)
CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung
EES Nieuwenhuis et al.
NATURE MEDICINE (2002)
A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1- CD4+ CD1d-dependent precursor stage
DG Pellicci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
JE Gumperz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Distinct functional lineages of human Vα-24 natural killer T cells
PT Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
MJ Smyth et al.
BLOOD (2002)
HLA class I antigen abnormalities and immune escape by malignant cells
B Seliger et al.
SEMINARS IN CANCER BIOLOGY (2002)
Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms
B Gansuvd et al.
HUMAN IMMUNOLOGY (2002)
CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain
J Jayawardena-Wolf et al.
IMMUNITY (2001)
NKT cells derive from double-positive thymocytes that are positively selected by CDId
L Gapin et al.
NATURE IMMUNOLOGY (2001)
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
LS Metelitsa et al.
JOURNAL OF IMMUNOLOGY (2001)
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice
R Nakagawa et al.
JOURNAL OF IMMUNOLOGY (2001)
Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
JJ Campbell et al.
JOURNAL OF IMMUNOLOGY (2001)
IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells
MK Levings et al.
JOURNAL OF IMMUNOLOGY (2001)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
M Terabe et al.
NATURE IMMUNOLOGY (2000)
CD27 is required for generation and long-term maintenance of T cell immunity
J Hendriks et al.
NATURE IMMUNOLOGY (2000)
Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes
MC Leite-De-Moraes et al.
JOURNAL OF IMMUNOLOGY (2000)
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-γ production by NK-T cells
B Bonish et al.
JOURNAL OF IMMUNOLOGY (2000)
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
JL Matsuda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
α-Glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro
S Ishihara et al.
JOURNAL OF IMMUNOLOGY (2000)
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
T Nishimura et al.
INTERNATIONAL IMMUNOLOGY (2000)
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
K Benlagha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells
MC Coles et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Human invariant Vα24+ natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
A Nicol et al.
IMMUNOLOGY (2000)
Murine CD1d-restricted T cell recognition of cellular lipids
JE Gumperz et al.
IMMUNITY (2000)
Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1
M Nakui et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)
分享论文
